Scibase Q2’24: Growth returns in the US - Redeye
Redeye saw a Q2 report showing sales slightly below our estimates, with a total growth of 31% for the quarter. Costs increased a bit more than expected, mainly driven by R&D. The gross margin was roughly in line at 69.1% vs. our estimate of 70%. The EBIT result was SEK -14.7m vs. our estimate of -13.2m. Growth continues well in Germany, and the US shows a strong rebound, still from low absolute levels. We do not expect to make significant changes to our Base case.
Länk till analysen i sin helhet: https://www.redeye.se/research/1031951/scibase-q224-growth-returns-in-the-us?utm_source=finwire&utm_medium=RSS
